Reuters logo
BRIEF-GSK submits marketing authorisation application to EMA for BRAF/MEK therapy
February 7, 2013 / 3:36 PM / 5 years ago

BRIEF-GSK submits marketing authorisation application to EMA for BRAF/MEK therapy

LONDON, Feb 7 (Reuters) - GlaxoSmithKline Plc : * EU submission for braf/mek combination therapy

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below